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Overview of presentation 
• Principles and practice of registration 
• Barriers and facilitators to registration  
• Development and evaluation of utility of PROSPERO 
• The future 
 
 
Principles of registration 
• Availability of evidence to inform health care decisions 
• Avoidance of publication bias and selective reporting bias 
• Requirement of The Declaration of Helsinki 
• Avoid unnecessary duplication 
• Identify gaps in research 
• Facilitate recruitment 
• Promoting collaboration 
• Early identification of potential problems 
WHO ICTRP: www.who.int/ictrp/en/  
Practice of registration  
• Accessible to the public at no charge 
• Accept registrations from anyone  
(unduplicated, eligible and complete)  
• Managed by a not-for-profit organisation  
• Validate entries (within scope and complete) 
• Electronically searchable 
• Provide a unique identification number for each record 
• Require provision of a minimum data set  
• Permanent entries 
 
ICMJE criteria for clinical trial registers: www.icmje.org/update_june07.html 
 
 
Publication bias and selective reporting 
of outcomes 
• In animal studies 
• Sena ES, van der Worp HB, Bath PM, et al: Publication bias in reports of animal stroke 
studies leads to major overstatement of efficacy. PLoS Biol. 2010 Mar 30;8(3):e1000344.  
• Kilkenny C, Parsons N, Kadyszewski E, et al. (2009) Survey of the Quality of Experimental 
Design, Statistical Analysis and Reporting of Research Using Animals. PLoS ONE 
4(11): e7824.  
• In clinical trials 
• Song F, Parekh S, Hooper L, et al: Dissemination and publication of research findings: 
an updated review of related biases. Health Technol Assess 2010, 14:1-193.  
• Smyth RM, Kirkham JJ, Jacoby A, et al. Frequency and reasons for outcome reporting 
bias in clinical trials: interviews with trialists. BMJ. 2011 Jan 6;342:c7153. 
• In systematic reviews 
• Tricco AC, Pham B, Brehaut J, et al. An international survey indicated that unpublished 
systematic reviews exist. Journal of clinical epidemiology 2009: 62(6):617-623.e5.  
• Kirkham JJ, Altman DG, Williamson PR (2010) Bias Due to Changes in Specified 
Outcomes during the Systematic Review Process. PLoS ONE 5(3): e9810. 
How registration can help  
• Records key planned features of the research 
• randomisation/inclusion criteria 
• primary and secondary outcomes and measures 
 
• Allows comparison of published results with what was planned 
in the corresponding registration record 
• readers can judge whether any discrepancies are likely to 
have introduced bias 
 
• Registration should allow amendments and maintain audit trail 
(not unreasonable to make changes, but need to know why) 
Avoiding unintended duplication  
• Research can be invasive/time consuming and costly 
• Often duplicate or very similar studies are undertaken 
• Unintended duplication is economically wasteful 
 
• Registration should allow those planning research to check 
whether there are any studies already in the ‘pipeline’ that 
address their topic of interest 
 
• They can then decide whether or not to proceed 
 
Practical barriers to registration 
• Availability of a registry 
  
• Process for process sake  
• no legal or ethical imperative: ? value to registrant 
• Safeguarding privacy 
• focus/topic of investigation 
• researchers carrying out the investigation 
• Timing 
• too soon – lots of amendments 
• too late – fails to fulfil purpose of registration 
• Costs 
• time, effort and money 
Benefits of registration 
• Researchers 
• Commissioners and funders 
• Guideline developers 
• Journal editors and peer reviewers 
• Methodologists 
• The public 
 
 
Prospective registration of systematic 
review protocols 
• Importance increasingly recognised 
 
• PRISMA 2009 advocated registration 
 
• No open access facility to formally 
register systematic review protocols 
• Cochrane and Campbell 
Collaboration protocol 
registration limited to their own 
organisations 
 
 
 
 
 
Development of PROSPERO 
• CRD initiated development of PROSPERO in 2010 
 
• International Advisory Group 
 
• Minimum dataset agreed by  
      international consultation 
• 22 required fields 
• 18 optional fields 
 
 
    Lancet 2011;377(9760):108-109 
  
 
 
Inclusion/exclusion and timing 
• Ongoing systematic reviews that have a health related outcome 
in the broadest sense 
• Systematic reviews of reviews 
• Reviews of methodological issues with an outcome that can be 
used in health care practice 
 
• Scoping reviews – excluded as are not systematic reviews 
• Reviews of animal studies – excluded as outcomes not of direct 
relevance in health care practice 
 
• Registered before screening against eligibility criteria 
commences (currently accepted as long as they have not 
progressed beyond the completion of data extraction) 
 
PROSPERO launched 
February 2011  
• Web based 
• Free to register, free to search 
• Users create and update their own records 
• Record content is responsibility of review author 
• Administrators check for “sense” not peer review 
• An audit trail of amendments is maintained 
• Registration record indexed by the PROSPERO team 
• As many administration tasks as possible are automated 
• Minimum data set 
 
One year evaluation of utility  
• Based on 232 responses from users (response rate 22%) 
• 80% found registration fields relevant to their review 
• 99% found joining and navigation was easy/very easy  
• 96% found turn round time was good/excellent  
• 80% found supporting materials helpful/very helpful 
• 99% rated their overall experience of registering with 
PROSPERO as good or excellent 
• 79% completed the registration form in 60 minutes or less 
• Conclusion: registration of systematic review protocols is 
feasible and not overly burdensome for those registering their 
reviews 
Booth et al.Systematic Reviews 2013;2:4 
Criticisms of the dataset 
• ‘Form bias towards reviews that involve statistical data analysis 
rather than narrative or qualitative reviews’ 
 
• ‘Some leaders assert that systematic reviews are exploratory in 
nature and should not have pre-determined primary outcomes’  
 
• Legitimate reasons why data extraction, risk of bias (quality) 
assessment and data analysis all started but not completed 
 
 
 
 
Cumulative totals for new registrations 
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Countries where registered 
reviews are being conducted 
March 2013: PROSPERO contains details of 1260 reviews 
being carried out in 57 different countries. 
The future 
• Improve functionality of form and search interface 
• Expand the scope to include all systematic reviews for which 
there is a health related outcome in the broadest sense 
• Continue to encourage registration and use of the database 
• Work on a programme of methodological research 
 
• Potentially help support development of satellites (X-3 or 
Miranda?) 
 
• With the right support and flexible pragmatic approach - setting 
up a register is possible 
 
www.crd.york.ac.uk/PROSPERO 
 
